$19.42
0.49[2.59%]
At close: Apr 26
$19.42
0[0.00%]
After Hours: 7:13PM EDT
Akero Therapeutics
(NASDAQ:AKRO)Latest News for Akero Therapeutics Stock (NASDAQ:AKRO)
Akero Therapeutics Stock (NASDAQ: AKRO)
Categories: All
Monday, April 22, 2024
Thursday, March 07, 2024
Wednesday, March 06, 2024
Tuesday, March 05, 2024
- Akero Therapeutics shares are trading lower after the company announced a $300 million public offering.Benzinga Newsdesk - Mar 5, 2024, 12:25PM
- UBS Maintains Buy on Akero Therapeutics, Raises Price Target to $42Benzinga Newsdesk - Mar 5, 2024, 9:43AM
- HC Wainwright & Co. Maintains Buy on Akero Therapeutics, Raises Price Target to $50Benzinga Newsdesk - Mar 5, 2024, 6:46AM
Monday, March 04, 2024
- Akero Therapeutics Begins Public Offering Of $300M Of Shares Of Its Common StockBenzinga Newsdesk - Mar 4, 2024, 4:23PM
- Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day SessionAvi Kapoor - Mar 4, 2024, 1:29PM
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Mar 4, 2024, 12:35PM
- Akero Therapeutics' Stock Is Soaring Monday - Here's WhyVandana Singh - Mar 4, 2024, 11:28AM
- Market-Moving News for March 4thBenzinga Newsdesk - Mar 4, 2024, 8:47AM
- Akero Therapeutics shares are trading higher after the company announced preliminary topline week 96 results from the HARMONY Phase 2B study of efruxifermin for pre-cirrhotic metabolic dysfunction-associated steatohepatitis, fibrosis stage 2 or 3.Benzinga Newsdesk - Mar 4, 2024, 7:49AM
- Akero Therapeutics Released Preliminary Topline Week 96 Results From HARMONY Phase 2B Study Of Efruxifermin For Pre-Cirrhotic Metabolic Dysfunction-associated Steatohepatitis, Fibrosis Stage 2 Or 3Benzinga Newsdesk - Mar 4, 2024, 6:06AM
- Super Micro Computer, Deckers Outdoor And Other Big Stocks Moving Higher In Monday's Pre-Market SessionAvi Kapoor - Mar 4, 2024, 5:01AM
Friday, March 01, 2024
Thursday, February 29, 2024
- 10 Health Care Stocks Whale Activity In Today's SessionBenzinga Insights - Feb 29, 2024, 12:35PM
- Akero Therapeutics To Present Topline Week 96 Results From Phase 2b HARMONY Study Investigating Efruxifermin In Patients With Pre-Cirrhotic MASHBenzinga Newsdesk - Feb 29, 2024, 8:46AM
- Akero Therapeutics: Q4 Earnings InsightsBenzinga Insights - Feb 29, 2024, 7:55AM
- Akero Therapeutics Q4 EPS $(0.99) Down From $(0.49) YoY; Cash, Cash Equivalents, Short-term And Long-term Marketable Securities Of $569.3M Is Will Be Sufficient To Fund The Company's Current Operating Plan Into 2026Benzinga Newsdesk - Feb 29, 2024, 7:11AM
Friday, February 23, 2024
Tuesday, February 06, 2024
Wednesday, November 22, 2023
Tuesday, November 14, 2023
Monday, November 13, 2023
Friday, October 13, 2023
Thursday, October 12, 2023
Wednesday, October 11, 2023
- Akero Therapeutics' Lead Candidate Potential: Analyst Unpacks Complicated Regulatory Path ForwardVandana Singh - Oct 11, 2023, 3:35PM
- JP Morgan Maintains Overweight on Akero Therapeutics, Lowers Price Target to $41Benzinga Newsdesk - Oct 11, 2023, 3:05PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Oct 11, 2023, 1:31PM
- Why Astra Space Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Oct 11, 2023, 1:13PM
- Akero Therapeutics shares are trading lower after multiple firms lowered their respective price targets.Benzinga Newsdesk - Oct 11, 2023, 12:44PM
- HC Wainwright & Co. Maintains Buy on Akero Therapeutics, Lowers Price Target to $40Benzinga Newsdesk - Oct 11, 2023, 12:31PM
- Cantor Fitzgerald Maintains Overweight on Akero Therapeutics, Lowers Price Target to $39Benzinga Newsdesk - Oct 11, 2023, 11:19AM
- Analyst Ratings for Akero TherapeuticsBenzinga Insights - Oct 11, 2023, 10:00AM
- Morgan Stanley Maintains Overweight on Akero Therapeutics, Lowers Price Target to $33Benzinga Newsdesk - Oct 11, 2023, 9:19AM
Tuesday, October 10, 2023
- Wegovy Maker Novo Nordisk, Akero Therapeutics, Eli Lilly, Athena Consumer Acquisition, Tesla: Why These 5 Stocks Are Trending TodayBenzinga Neuro - Oct 10, 2023, 9:56PM
- Akero Therapeutics' Disappointing NASH Data Drags Its RivalVandana Singh - Oct 10, 2023, 2:48PM
- Crude Oil Moves Lower; Neogen Posts Downbeat ResultsLisa Levin - Oct 10, 2023, 2:46PM
- Big Pharma Could Transform Into BioTech PharmaUpwallstreet - Oct 10, 2023, 1:53PM
- 12 Health Care Stocks Moving In Tuesday's Intraday SessionBenzinga Insights - Oct 10, 2023, 1:31PM
- Stocks That Hit 52-Week Lows On TuesdayBenzinga Insights - Oct 10, 2023, 1:09PM
- Why Startek Shares Are Trading Higher By 29%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionLisa Levin - Oct 10, 2023, 1:08PM
- S&P 500 Rises 1%; US Wholesale Inventories Fall In AugustLisa Levin - Oct 10, 2023, 12:04PM
- PagerDuty, John Wiley & Sons, Ventyx Biosciences And Other Big Stocks Moving Lower On TuesdayLisa Levin - Oct 10, 2023, 11:37AM
- Why Is Liver Disease Focused Akero Therapeutics Stock Sinking Today?Vandana Singh - Oct 10, 2023, 10:28AM
- US Stocks Gain; PepsiCo Posts Upbeat EarningsLisa Levin - Oct 10, 2023, 9:40AM